From Sex Without Babies To Babies Without Sex

The birth of more than 2,000 babies by extracorporeal fertilization and uterine transfer of cleaving embryos has made human embryos the tools of baby manufacturing. It has led to the opening of in vitro fertilization (IVF) clinics in greater numbers and seems to have encouraged more research on human embryos to improve the success rate of IVF procedures. This has resulted in the storage of excess embryos by freeze-thaw techniques and has paved the way for research on embryos as young as 14 days.

Written byDs Sheriff
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In an era of such artificial methods of reproduction, "high-tech" baby manufacturing seems to have become another flourishing industry. The institution of fetal cell therapy, the shortage of donor organs for transplantation, and the craze for pre-selection of the sex of developing fetuses may further encourage research on human embryos that may end up in eugenic manipulation, inter-species fertilization, or the growing of fetuses to the stage of organ development for transplantation.

The recent restrictions imposed by the Council of Europe on such activities (The Scientist, October 20, 1986, p. 8) indirectly support the possibility of such abuse. Apart from being judged on sound scientific understanding, human embryo research must be governed by elements of human belief, values and social factors.

The human embryo bears the blueprint of human life. Research must not threaten that future life. One can create babies through such methods, but one cannot instill emotions and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies